We have investigated the W64R (Trp64Arg) mutation in the b b-3-adrenergic receptor in 2270 healthy British males aged 50±61 y. The frequency of the rare R allele was 0.07 (95% con®dence interval (CI) 0.06-0.08). The men showed an absence of association between W64R genotype and weight or height, both in the whole sample and in each quintile of the body mass index (BMI), and there was no association with tendency to gain weight. The W64R heterozygous state appears not to be a major contributing factor to obesity in the general population.
Introduction
Obesity has a heterogeneous and multifactorial phenotype, and several susceptibility genes (in addition to environmental factors) are likely to be required for expression. One of these may be the b-3-adrenergic receptor. Activity is thought to be more prominent in visceral than in subcutaneous adipose tissue, 1 where defective expression at the cell surface or impaired signalling could lead to the development of metabolic disturbances common in abdominal obesity, 2 which is particularly associated with the risk of cardiovascular disorders.
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In 1995, three separate investigations 4±6 reported a missense mutation in the b-3-adrenergic receptor gene that leads to the replacement of tryptophan by arginine (Trp64Arg or W64R) in the receptor, and each showed an association between W64R and weight in different ethnic groups exhibiting different obesityrelated pathologies. Since then a range of studies differing in ethnicity and phenotypic traits have been undertaken, with con¯icting results. 7 We have investigated W64R impact in a large population sample ensuring good statistical power, representing developing traits in healthy subjects, in contrast with previous studies mostly investigating fully developed pathologies.
Materials and methods

Study samples
The Northwick Park Heart Study II (NPHS II) sample comprises healthy adult males aged 50±61 y, 8 of which an unselected group of 2270 individuals from nine widespread UK general practices were studied here.
Polymerase chain reaction (PCR)
Genomic DNA was isolated from frozen whole blood. 9 The PCR primers (Genosys, Cambridge, UK) were as described by Cle Âment et al, 6 but we used MspI digestion in place of BstNI for genotyping. There are two MspI sites in the normal sequence, with a third MspI site created by the mutation. PCR setup and cycling conditions were as described by Whittall et al.
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MspI digestion of PCR products and genotyping by polyacrylamide gel electrophoresis MspI and buffer (New England Biolabs, Beverly, MA, USA) were used in digests set up as described by Bolla et al, 11 with 1.0 U of enzyme per 10 ml digestion volume. Genotyping was by sizing of the digestion products by electrophoresis on a 7.5% polyacrylamide microplate array diagonal gel electrophoresis (MADGE) 12 gel.
Statistical analysis
Hardy-Weinberg equilibrium was examined by chisquared test. Comparison of parameters in the NPHS II sample with respect to W64R genotype was by oneway ANOVA.
Results
The genotypes were in Hardy-Weinberg equilibrium.
Tests of association between W64R genotype (rare R allele frequency 0.07, 95% con®dence interval (CI) 0.06±0.08) and height, weight and body mass index (BMI) in the NPHS II sample are shown in Table 1 .
The mean weight and BMI of the WW homozygotes were equal to WR heterozygotes, and although the mean weight of the 12 rare RR homozygotes was 5.6 kg lower than that of the WW individuals, and BMI 1.7 kgam 2 lower, these differences were not statistically signi®cant. The rare allele frequency of 0.07 was the same in all quintiles of BMI, and there was no signi®cant association between weight and W64R genotype in any quintile, (data not shown). Furthermore we found no difference in R allele frequency in quintiles of weight gained over the ®ve year period of the study (results not shown).
Discussion
These studies have investigated the W64R mutation in the b-3-adrenergic receptor gene, 4±6 in a group of Caucasoid middle-aged men. The frequency of the mutant allele was 0.07. The frequency is reportedly uniform within similar population groups, whether obese, diabetic or normal, although it varies widely between ethnic groups, from 0.08 to 0.13 in French, Finns and Americans, 4 to 0.31 in Pima Indians 4±6 and 0.37 in Japanese. 13 There was no signi®cant difference in weight or height associated with W64R genotype in the sample as a whole or in any quintile of BMI. The mean weight of the rare RR homozygotes was lower than that of the common WW homozygotes, an opposite effect to that expected if the W64R mutation predisposed obesity, but the difference was not signi®cant.
The W64R mutation may contribute to the capacity to gain weight, or have an effect unmasked in persons only at high risk of obesity due to other genetic or environmental factors. We examined the frequency of the R allele in quintiles of weight gained over the ®ve year period of the study. There was no difference in the allele frequency in the ®ve groups, showing that in this sample of non-obese men, carriers of the R allele showed no tendency to gain weight with respect to non-carriers (results not shown).
The signi®cance of W64R for obesity and insulin resistance has been questioned, 14 citing no difference between carriers and non-carriers of the R allele for several obesity-related phenotypes, including abdominal visceral fat level, using both association and linkage analyses. These results throw doubt on the hypotheseis that an altered receptor mutation could lead to enlargement of the abdominal fat depot, in which the receptor seems preferentially expressed. 1 Other studies have found the R allele is not associated with BMI, fat distribution, metabolic variables, visceral fat cell size and lipolytic response to noradrenaline, in normal weight or obese non-diabetic individuals. 15 However, a number of Japanese studies have shown an association of the mutant allele with BMI, 13, 16, 17 with visceral fat, 18 and with a blunted response to treatment of obesity in women. 19 The high frequency of the W64R mutation reported in nonobese Japanese subjects, 17 together with uniform allele frequency with respect to BMI within ethnic groups suggests that the mutation itself is not a major determinant of obesity. Our results, the largest study undertaken to date, reinforce this conclusion. 
